BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34716589)

  • 1. A disease network-based deep learning approach for characterizing melanoma.
    Lai X; Zhou J; Wessely A; Heppt M; Maier A; Berking C; Vera J; Zhang L
    Int J Cancer; 2022 Mar; 150(6):1029-1044. PubMed ID: 34716589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma.
    Li W; Huang Q; Peng Y; Pan S; Hu M; Wang P; He Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15923-15938. PubMed ID: 37673824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning.
    Li X; Yu X; Tian D; Liu Y; Li D
    Med Phys; 2023 Nov; 50(11):7049-7059. PubMed ID: 37722701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data.
    Lu X; Zhang Q; Wang Y; Zhang L; Zhao H; Chen C; Wang Y; Liu S; Lu T; Wang F; Yan F
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1635-1647. PubMed ID: 29948145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis.
    Li X; Cai Y
    Aging (Albany NY); 2019 Jul; 11(14):5081-5107. PubMed ID: 31322504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
    Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
    Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Deep Learning on the Prognosis of Cutaneous Melanoma Based on Full Scan Pathology Images.
    Li A; Li X; Li W; Yu X; Qi M; Li D
    Biomed Res Int; 2022; 2022():4864485. PubMed ID: 36072469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
    Rajkumar S; Watson IR
    Br J Cancer; 2016 Jul; 115(2):145-55. PubMed ID: 27336610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
    Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
    NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
    Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
    Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
    Peng Y; Chu Y; Chen Z; Zhou W; Wan S; Xiao Y; Zhang Y; Li J
    World J Surg Oncol; 2020 Jun; 18(1):130. PubMed ID: 32546168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 13. PAGE-Net: Interpretable and Integrative Deep Learning for Survival Analysis Using Histopathological Images and Genomic Data.
    Hao J; Kosaraju SC; Tsaku NZ; Song DH; Kang M
    Pac Symp Biocomput; 2020; 25():355-366. PubMed ID: 31797610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
    Vural S; Wang X; Guda C
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):62. PubMed ID: 27587275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.
    Ma EZ; Hoegler KM; Zhou AE
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. scan_tcga tools for integrated epigenomic and transcriptomic analysis of tumor subgroups.
    Chatterjee A; Stockwell PA; Rodger EJ; Parry MF; Eccles MR
    Epigenomics; 2016 Oct; 8(10):1315-1330. PubMed ID: 27625317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.
    Jiang Y; Shi X; Zhao Q; Krauthammer M; Rothberg BE; Ma S
    Genomics; 2016 Jun; 107(6):223-30. PubMed ID: 27141884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSAE: an autoencoder with embedded gene-set nodes for genomics functional characterization.
    Chen HH; Chiu YC; Zhang T; Zhang S; Huang Y; Chen Y
    BMC Syst Biol; 2018 Dec; 12(Suppl 8):142. PubMed ID: 30577835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
    Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C
    Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.